loadpatents
Patent applications and USPTO patent grants for Shimma; Nobuo.The latest application filed is for "combination therapy using ascochlorin derivative".
Patent | Date |
---|---|
Combination therapy using ascochlorin derivative Grant 11,298,358 - Hoshino , et al. April 12, 2 | 2022-04-12 |
Combination Therapy Using Ascochlorin Derivative App 20210346390 - HOSHINO; Tatsuo ;   et al. | 2021-11-11 |
Ascochlorin derivative and use thereof as AMPK activator Grant 10,968,186 - Shimma , et al. April 6, 2 | 2021-04-06 |
Ascochlorin Derivative And Use Thereof As Ampk Activator App 20200270220 - SHIMMA; Nobuo ;   et al. | 2020-08-27 |
4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication Grant 8,648,054 - Devos , et al. February 11, 2 | 2014-02-11 |
Heteroarylphenylurea derivative Grant 8,609,656 - Oikawa , et al. December 17, 2 | 2013-12-17 |
5-substituted-2-phenylamino benzamides as MEK inhibitors Grant 8,575,391 - Isshiki , et al. November 5, 2 | 2013-11-05 |
4'-substituted Nucleoside Derivatives As Inhibitors Of Hcv Rna Replication App 20130237491 - Devos; Rene Robert ;   et al. | 2013-09-12 |
Macrocyclic compound Grant 8,362,236 - Shimma , et al. January 29, 2 | 2013-01-29 |
Pyrazolopyridine and pyrrolopyridine multikinase inhibitors Grant 8,299,252 - Ozawa , et al. October 30, 2 | 2012-10-30 |
4'-substituted Nucleoside Derivatives As Inhibitors Of Hcv Rna Replication App 20120034184 - Devos; Rene Robert ;   et al. | 2012-02-09 |
4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors Grant 8,084,645 - Isshiki , et al. December 27, 2 | 2011-12-27 |
4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication Grant 8,071,567 - Devos , et al. December 6, 2 | 2011-12-06 |
Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes Grant 8,048,897 - Matsuoka , et al. November 1, 2 | 2011-11-01 |
Pyrimidine derivatives as PI3K inhibitor and use thereof Grant 8,022,205 - Shimma , et al. September 20, 2 | 2011-09-20 |
4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication Grant 7,915,232 - Martin , et al. March 29, 2 | 2011-03-29 |
5-Substituted-2-Phenylamino Benzamides as Mek Inhibitors App 20100197676 - Isshiki; Yoshiaki ;   et al. | 2010-08-05 |
Multikinase Inhibitor App 20100168430 - Ozawa; Sawako ;   et al. | 2010-07-01 |
5-Substituted-2-phenylamino benzamides as MEK inhibitors Grant 7,745,663 - Isshiki , et al. June 29, 2 | 2010-06-29 |
Pyrimidine Derivatives As Pi3k Inhibitor And Use Thereof App 20100069629 - Shimma; Nobuo ;   et al. | 2010-03-18 |
Macrocyclic Compound App 20100056510 - Shimma; Nobuo ;   et al. | 2010-03-04 |
4'-substituted Nucleoside Derivatives As Inhibitors Of Hcv Rna Replication App 20100003213 - Devos; Rene Robert ;   et al. | 2010-01-07 |
4'-Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication App 20100004192 - Martin; Joseph Armstrong ;   et al. | 2010-01-07 |
4'-Substituted nucleoside derivatives as inhibitors of HCV RNA replication Grant 7,608,601 - Devos , et al. October 27, 2 | 2009-10-27 |
5-Substituted-2-Phenylamino Benzamides as MEK Inhibitors App 20090233915 - Isshiki; Yoshiaki ;   et al. | 2009-09-17 |
Novel Cyclohexane Derivative, Prodrug Thereof and Salt Thereof, and Therapeutic Agent Containing the Same for Diabetes App 20080318874 - Matsuoka; Hiroharu ;   et al. | 2008-12-25 |
N-substituted carbamoyloxyalkyl-azolium derivatives Grant 7,459,561 - Fukuda , et al. December 2, 2 | 2008-12-02 |
Heteroarylphenylurea Derivative App 20080119466 - Oikawa; Nobuhiro ;   et al. | 2008-05-22 |
4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors App 20070105859 - Isshiki; Yoshiaki ;   et al. | 2007-05-10 |
N-phenyl substituted carbamoyloxyalkyl-azolium derivatives Grant 7,189,858 - Fukuda , et al. March 13, 2 | 2007-03-13 |
N-substituted carbamoyloxyalkyl-azolium derivatives App 20070027322 - Fukuda; Hiroshi ;   et al. | 2007-02-01 |
Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives Grant 7,151,182 - Fukuda , et al. December 19, 2 | 2006-12-19 |
Hexacyclic compounds and their therapeutic use Grant 7,109,195 - Murata , et al. September 19, 2 | 2006-09-19 |
Novel hexacyclic compounds App 20050059679 - Murata, Takeshi ;   et al. | 2005-03-17 |
Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives App 20050038075 - Fukuda, Hiroshi ;   et al. | 2005-02-17 |
N-phenyl substituted carbamoyloxyalkyl-azolium derivatives App 20050038038 - Fukuda, Hiroshi ;   et al. | 2005-02-17 |
Aerothricin derivatives Grant 6,849,709 - Kohchi , et al. February 1, 2 | 2005-02-01 |
4'-Substituted nucleoside derivatives as inhibitors of HCV RNA replication App 20040266722 - Devos, Rene Robert ;   et al. | 2004-12-30 |
Hexacyclic compounds Grant 6,825,194 - Murata , et al. November 30, 2 | 2004-11-30 |
N-substituted carbamoyloxyalkyl-azolium derivatives Grant 6,812,238 - Fukuda , et al. November 2, 2 | 2004-11-02 |
4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication. Grant 6,784,166 - Devos , et al. August 31, 2 | 2004-08-31 |
Anti-HCV nucleoside derivatives App 20040110718 - Devos, Rene ;   et al. | 2004-06-10 |
4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication App 20030236216 - Devos, Rene Robert ;   et al. | 2003-12-25 |
Novel hexacyclic compounds App 20030144304 - Murata, Takeshi ;   et al. | 2003-07-31 |
Method for identifying an enzyme to design anti-cancer compounds App 20030138864 - Ishitsuka, Hideo ;   et al. | 2003-07-24 |
Anti-HCV nucleoside derivatives App 20030008841 - Devos, Rene ;   et al. | 2003-01-09 |
Azole derivatives App 20010047017 - Komiyama, Susumu ;   et al. | 2001-11-29 |
Intranasal cyclic peptide formulations App 20010038824 - Horii, Ikuo ;   et al. | 2001-11-08 |
Aerothricin derivatives App 20010031728 - Kohchi, Masami ;   et al. | 2001-10-18 |
5'-deoxy-cytidine derivative administration to treat solid tumors Grant 6,211,166 - Hattori , et al. April 3, 2 | 2001-04-03 |
5'-deoxy-cytidine derivatives Grant 6,114,520 - Hattori , et al. September 5, 2 | 2000-09-05 |
5'deoxycytidine derivatives Grant 6,005,098 - Hattori , et al. December 21, 1 | 1999-12-21 |
N.sup.4 -(substituted-oxycarbonyl)-5'-deoxy-5-fluorocytidine compounds, compositions and methods of using same Grant 5,472,949 - Arasaki , et al. December 5, 1 | 1995-12-05 |
Pyrido(3,2,1-IJ)-1,3,4-benzoxadiazine derivatives Grant 4,864,023 - Yokose , et al. September 5, 1 | 1989-09-05 |
Pyrido(3,2,1-IJ)-1,3,4 benzoxadiazine derivatives Grant 4,801,584 - Yokose , et al. January 31, 1 | 1989-01-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.